CTI
Live / Registered — Registered and renewed (as of 13 Jul 2023)
What this means for you
Registered since 14 Jan 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jan 2023).
Record
- Serial number
- 76388984
- Registration number
- 2674894
- Mark type
- Word mark
- Filed
- 28 Mar 2002
- Published for opposition
- 22 Oct 2002
- Registered
- 14 Jan 2003
- Next maintenance due
- 14 Jan 2023
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the treatment of cancer; and pharmaceutical preparations used for the treatment of immunological and inflammatory diseases, infections secondary to the oncologic disease, and the management of pain accompanying either the disease process or the associated treatment regimens
Owner
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
Prior registrations
Prosecution history
- 14 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 Jul 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 13 Jul 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Dec 2022 — TEAS SECTION 8 & 9 RECEIVED
- 14 Jan 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Jun 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 14 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 May 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 May 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 May 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 May 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS